Back to Search
OLIVIA ARANHA, MD
MD
Medical Oncology Physician
NPI: 1386841211IndividualAccepts Medicare
Specialties, Licenses & Credentials
Education
OTHER
Class of 1995
Research & Publications (13)
CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with CD23- disease.
PMID 18628084·Am J Clin Pathol·2008
4-observational
New therapeutic options in gastrointestinal stromal tumors.
PMID 18409663·Oncology (Williston Park)·2008
6-review
Molecularly targeted therapies in adult soft tissue sarcomas: present approach and future directions.
PMID 18208368·Expert Opin Ther Targets·2008
6-review
Sequence dependent potentiation of gemcitabine by flavopiridol in human breast cancer cells.
PMID 15770523·Breast Cancer Res Treat·2005
8-other
Sensitization of human breast cancer cells to gemcitabine by the protein kinase C modulator bryostatin 1.
PMID 12811511·Cancer Chemother Pharmacol·2003
8-other
Indole-3-carbinol (I3C) induces apoptosis in tumorigenic but not in nontumorigenic breast epithelial cells.
PMID 12791510·Nutr Cancer·2003
7-preclinical
Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
PMID 12632069·Int J Oncol·2003
8-other
Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells.
PMID 12063570·Int J Oncol·2002
8-other
Role of mitochondria in ciprofloxacin induced apoptosis in bladder cancer cells.
PMID 11832715·J Urol·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 4921 PARKVIEW PL, DIV IM MEDICAL ONCOLOGY, STE 7A, 7B, 7C
SAINT LOUIS, MO 63110 - Phone
- (800) 647-2098
Quick Facts
- NPI
- 1386841211
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 31
- Publications
- 13
Are you this provider?
Claim Your Profile